Certara, a firm that accelerates medicines to patients using biosimulation software and technology, agreed to acquire Integrated Nonclinical Development Solutions, a provider of the SEND Explorer software and drug development consulting. Financial terms were not disclosed. “We are thrilled to join Certara and be part of a bigger future together. This is a great fit on multiple levels – technology, talent and mission to accelerate medicines. We are enthusiastic about the opportunities this combination presents for INDS and our clients," James R. Herman, INDS President.